GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (STU:SG0) » Definitions » Research & Development

FibroBiologics (STU:SG0) Research & Development : €2.63 Mil (TTM As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is FibroBiologics Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. FibroBiologics's Research & Development for the three months ended in Mar. 2024 was €0.88 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was €2.63 Mil.

FibroBiologics Research & Development Historical Data

The historical data trend for FibroBiologics's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FibroBiologics Research & Development Chart

FibroBiologics Annual Data
Trend Dec21 Dec22 Dec23
Research & Development
0.46 1.08 2.17

FibroBiologics Quarterly Data
Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only 0.45 0.50 0.54 0.71 0.88

FibroBiologics Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €2.63 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

FibroBiologics  (STU:SG0) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

FibroBiologics Research & Development Related Terms

Thank you for viewing the detailed overview of FibroBiologics's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

FibroBiologics (STU:SG0) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » FibroBiologics Inc (STU:SG0) » Definitions » Research & Development
Comparable Companies
Traded in Other Exchanges
FBLG:USA
Address
455 E. Medical Center Boulevard, Suite 300, Houston, TX, USA, 77598
Website
https://www.fibrobiologics.com
FibroBiologics Inc is an early-stage, cell therapy company. Its primary focus is the initiation and progression of preclinical studies and clinical-stage FDA trials related to fibroblast treatments for Degenerative Disc Disease, Multiple Sclerosis, Cancer, Wound Healing, and other diseases.

FibroBiologics (STU:SG0) Headlines

No Headlines